International regulatory needs for development of an IATA for non-genotoxic carcinogenic chemical substances

Altex

Volumn 33, Issue 4, 2016, Pages 359-392

  Jacobs, Miriam N ^a   Colacci, Annamaria ^b   Louekari, Kimmo ^c   Luijten, Mirjam ^d   Hakkert, Betty C ^d   Paparella, Martin ^e   Vasseur, Paule ^f  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b Excellence Environmental Carcinogenesis   (Italy)

^c EUROPEAN CHEMICALS AGENCY   (Finland)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e ENVIRONMENT AGENCY AUSTRIA   (Austria)

^f UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Integrated approaches to testing and assessment of chemicals; Non genotoxic carcinogens

Indexed keywords

CARCINOGEN; CHEMICAL COMPOUND; NON GENOTOXIC CARCINOGEN; UNCLASSIFIED DRUG; DANGEROUS GOODS;

ADVERSE OUTCOME; ARTICLE; BIOLOGICAL TRAIT; CANCER MODEL; CANCER RISK; CARCINOGEN TESTING; CARCINOGENESIS; CARCINOGENICITY; COMPUTER MODEL; GENOTOXICITY; GENOTOXICITY ASSAY; HAZARD ASSESSMENT; HUMAN; IN VITRO STUDY; LAW; NONHUMAN; ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); RISK ASSESSMENT; SYSTEMATIC REVIEW (TOPIC); TISSUE PERFUSION; ANIMAL; ANIMAL TESTING ALTERNATIVE; BIOASSAY; DANGEROUS GOODS; INTERNATIONAL COOPERATION; MUTAGEN TESTING; PROCEDURES; TOXICITY;

ANIMAL TESTING ALTERNATIVES; ANIMALS; BIOLOGICAL ASSAY; CARCINOGENICITY TESTS; CARCINOGENS; HAZARDOUS SUBSTANCES; INTERNATIONALITY; MUTAGENICITY TESTS;

EID: 84994742972     PISSN: 1868596X     EISSN: 18688551     Source Type: Journal    
DOI: 10.14573/altex.1601201     Document Type: Article

References (198)

1. Albanito, L., Lappano, R., Madeo, A. et al. (2015). Effects of atrazine on estrogen receptor alpha-and G protein-coupled receptor 30-mediated signaling and proliferation in cancer cells and cancer-associated fibroblasts. Environ Health Perspect 123, 493-499. http://dx.doi.org/10.1289/ehp.1408586
2. Albini, A. and Noonan, D. M. (2010). The 'chemoinvasion' assay, 25 years and still going strong: The use of reconstituted basement membranes to study cell invasion and angiogenesis. Curr Opin Cell Biol 22, 677-689. http://dx.doi.org/10.1016/j.ceb.2010.08.017
3. Alden, C. L., Lynn, A., Bourdeau, A. et al. (2011). A critical review of the effectiveness of rodent pharmaceutical carcinogenesis testing in predicting for human risk. Vet Pathol 48, 772-784. http://dx.doi.org/10.1177/0300985811400445
4. Ankley, G. T., Bennett, R. S., Erickson, R. J. et al. (2010). Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29, 730-741. http://dx.doi.org/10.1002/etc.34
5. Annys, E., Billington, R., Clayton, R. et al. (2014). Advancing the 3Rs in regulatory toxicology -carcinogenicity testing: Scope for harmonisation and advancing the 3Rs in regulated sectors of the European Union. Regul Toxicol Pharmacol 69, 234-242. http://dx.doi.org/10.1016/j.yrtph.2014.04.009
6. Arora, S., Saini, S., Fukuhara, S. et al. (2013). MicroRNA-4723 inhibits prostate cancer growth through inactivation of the Abelson family of nonreceptor protein tyrosine kinases. PLoS One 8, e78023. http://dx.doi.org/10.1371/journal.pone.0078023
7. Ashby, J. and Tennant, R. W. (1991). Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat Res 257, 229-306. http://dx.doi.org/10.1016/0165-1110(91)90003-E
8. Ball, M. P., Li, J. B., Gao, Y. et al. (2009). Targeted and genomescale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol 27, 361-368. http://dx.doi.org/nbt.1533
9. Bakkar, A., Alshalalfa, M., Petersen, L. F. et al. (2016). microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients. Mol Biol Rep 43, 229-240. http://dx.doi.org/10.1007/s11033-016-3948-4
10. Basketter, D. A., Clewell, H., Kimber, I. et al. (2012). A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing -t4 report ALTEX 29, 3-91. http://dx.doi.org/10.14573/altex.2012.1.003
11. Beiter, T., Reich, E., Williams, R. W. et al. (2009). Antisense transcription: A critical look in both directions. Cell Mol Life Sci 66, 94-112. http://dx.doi.org/10.1007/s00018-008-8381-y
12. Benigni, R. (2012). Alternatives to the carcinogenicity bioassay for toxicity prediction: Are we there yet? Expert Opin Drug Metab Toxicol 8, 407-417. http://dx.doi.org/10.1517/17425255.2012.6 66238
13. Benigni, R., Bossa, C. and Tcheremenskaia, O. (2013). Nongenotoxic carcinogenicity of chemicals: Mechanisms of action and early recognition through a new set of structural alerts. Chem Rev 113, 2940-2957. http://dx.doi.org/10.1021/cr300206t
14. Benigni, R. (2014). Predicting the carcinogenicity of chemicals with alternative approaches: Recent advances. Expert Opin Drug Metab Toxicol 10, 1199-1208. http://dx.doi.org/10.1517/17425255.2014.934670
15. Bernstein, E., Muratore-Schroeder, T. L., Diaz, R. L. et al. (2008). A phosphorylated subpopulation of the histone variant macroH2A1 is excluded from the inactive X chromosome and enriched during mitosis. Proc Nat Acad Sci U S A 105, 1533-1538. http://dx.doi.org/10.1073/pnas.0711632105
16. Bessi, H., Rast, C., Rether, B. et al. (1995). Synergistic effects of Chlordane and TPA in multistage morphological transformation of SHE cells. Carcinogenesis 16, 237-244. http://dx.doi.org/10.1093/carcin/16.2.237
17. Bhatia, S. N. and Ingber, D. E. (2014). Microfluidic organs-onchips. Nat Biotechnol 32, 760-772. http://dx.doi.org/10.1038/nbt.2989
18. Bibikova, M., Barnes, B., Tsan, C. et al. (2011). High density DNA methylation array with single CpG site resolution. Genomics 98, 288-295. http://dx.doi.org/10.1016/j.ygeno.2011.07.007
19. Billington, R., Lewis, R. W., Mehta, J. M. et al. (2010). The mouse carcinogenicity study is no longer a scientifically justifiable core data requirement for the safety assessment of pesticides. Crit Rev Toxicol 40, 35-49. http://dx.doi.org/10.3109/10408440903367741
20. Biswas, G., Srinivasan, S., Anandatheerthavarada, H. K. et al. (2008). Dioxin-mediated tumor progression through activation of mitochondria-to-nucleus stress signaling. Proc Nat Acad Sci U S A 105, 186-191. http://dx.doi.org/10.1073/pnas.0706183104
21. Biswas, S. K. and Mantovani, A. (2010). Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm. Nat Immunol 11, 889-896. http://dx.doi.org/10.1038/ni.1937
22. Black, A. T., Gray, J. P., Shakarjian, M. P. et al. (2008). Increased oxidative stress and antioxidant expression in mouse keratinocytes following exposure to paraquat. Toxicol Appl Pharmacol 231, 384-392. http://dx.doi.org/10.1196/annals.1432.020
23. Browne, P., Judson, R. S., Casey, W. M. et al. (2015). Screening chemicals for estrogen receptor bioactivity using a computational model. Environ Sci Technol 49, 8804-8814. http://dx.doi.org/10.1021/acs.est.5b02641
24. Caporali, A. and Emanueli, C. (2011). MicroRNA regulation in angiogenesis. Vascul Pharmacol 55, 79-86. http://dx.doi.org/10.1016/j.vph.2011.06.006
25. Casey, S. C., Vaccari, M., Al-Mulla, F. et al. (2015). The effect of environmental chemicals on the tumor microenvironment. Carcinogenesis 36, Suppl 1, S160-183. http://dx.doi.org/10.1093/carcin/bgv035
26. Chang, X., Lu, W., Dou, T. et al. (2013). Paraquat inhibits cell viability via enhanced oxidative stress and apoptosis in human neural progenitor cells. Chem Biol Interact 206, 248-255. http://dx.doi.org/10.1016/j.cbi.2013.09.010
27. Chepelev, N. L., Moffat, I. D., Labib, S. et al. (2015). Integrating toxicogenomics into human health risk assessment: Lessons learned from the benzo[a]pyrene case study. Crit Rev Toxicol 45, 44-52. http://dx.doi.org/10.3109/10408444.2014.973935
28. Choudhari, S. K., Chaudhary, M., Bagde, S. et al. (2013). Nitric oxide and cancer: A review. World J Surg Oncol 11, 118. http://dx.doi.org/10.1186/1477-7819-11-118
29. Corton, J. C., Cunningham, M. L., Hummer, B. T. et al. (2014). Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARalpha) as a case study. Crit Rev Toxicol 44, 1-49. http://dx.doi.org/10.3109/10408444.2013.835784
30. Creton, S., Aardema, M. J., Carmichael, P. L. et al. (2012). Cell transformation assays for prediction of carcinogenic potential: State of the science and future research needs. Mutagenesis 27, 93-101. http://dx.doi.org/10.1093/mutage/ger053
31. Cruciani, V. R., Mikalsen, S. O., Vasseur, P. et al.(1997). Effects of peroxisome proliferators and 12-O-tetradecanoyl phorbol-13-acetate on intercellular communication and connexin43 in two hamster fibroblast systems. Int J Cancer 73, 240-248. http://dx.doi.org/10.1002/(SICI)1097-0215(19971009)73:2 3.0.CO;2-J
32. Cruciani, V., Rast, C., Alexandre, S. et al. (1999). Peroxisome proliferator-induced transformation of Syrian hamster embryo cells: Influence of experimental procedures. Toxicol In Vitro 13, 445-457. http://dx.doi.org/10.1016/S0887-2333(99)00016-8
33. Davis, C. D., Uthus, E. O. and Finley, J. W. (2000). Dietary selenium and arsenic affect DNA methylation in vitro in Caco-2 cells and in vivo in rat liver and colon. J Nutr 130, 2903-2909.
34. Dhalluin, S., Gate, L., Vasseur, P. et al. (1997). Dysregulation of ornithine decarboxylase activity, apoptosis and Bcl-2 oncoprotein in Syrian hamster embryo cells stage-exposed to di(2-ethylhexyl) phthalate and tetradecanoylphorbol acetate. Carcinogenesis 18, 2217-2223. http://dx.doi.org/10.1093/carcin/18.11.2217
35. Dhalluin, S., Elias, Z., Cruciani, V. et al. (1998). Two-stage exposure of syrian-hamster-embryo cells to environmental carcinogens: Superinduction of ornithine decarboxylase correlates with increase of morphological-transformation frequency. Int J Cancer 75, 744-749. http://dx.doi.org/10.1002/(SICI)1097-0215(19980302)75:53.0.CO;2-6
36. Dicker, E. and Cederbaum, A. I. (1992). Increased NADH-dependent production of reactive oxygen intermediates by microsomes after chronic ethanol consumption: Comparisons with NADPH. Arch Biochem Biophys 293, 274-280. http://dx.doi.org/10.1016/0003-9861(92)90395-D
37. Doull, J., Cattley, R., Elcombe, C. et al. (1999). A cancer risk assessment of di(2-ethylhexyl)phthalate: Application of the new U.S. EPA risk assessment guidelines. Regul Toxicol Pharmacol 29, 327-357. http://dx.doi.org/10.1006/rtph.1999.1296
38. Down, T. A., Rakyan, V. K., Turner, D. J. et al. (2008). A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat Biotechnol 26, 779-785. http://dx.doi.org/10.1038/nbt1414
39. EC (2008). Council Regulation (EC) No 440/2008 of 30 May 2008 laying down test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). Official Journal L 142.
40. ECHA (2008). Guidance on information requirements and chemical safety assessment. Chapter R.6: QSARs and grouping of chemicals, May 2008. http://echa.europa.eu/documents/10162/13632/information-requirements-r6-en.pdf
41. ECHA (2014). The Use of Alternatives to Testing on Animals for the REACH Regulation. Second report under Article 117(3) of the REACH Regulation, 2014.
42. ECHA, Committee for Risk Assessment -RAC (2015). Opinion proposing harmonised classification and labelling at EU level of Terbuthylazine (ISO); N-tert-butyl-6-chloro-N'-ethyl-1,3,5-triazine-2,4-diamine EC Number: 227-637-9 CAS Number: 915-41-3, CLH-O-0000001412-86-66/F. Adopted 05 June 2015. http://echa.europa.eu/documents/10162/13579/clh-odd-rac-terbuthylazine-en.pdf
43. ECHA (2015). Read-Across Assessment Framework (RAAF), ECHA-15-R-07-EN. May 2015. http://echa.europa.eu/documents/10162/13628/raaf-en.pdf
44. EFSA (2013). Scientific Opinion on the hazard assessment of endocrine disruptors: Scientific criteria for identification of endocrine disruptors and appropriateness of existing test methods for assessing effects mediated by these substances on human health and the environment. EFSA J 11, 84. http://dx.doi.org/10.2903/j.efsa.2013.3132
45. EFSA (2014). A systematic procedure for the identification of emerging chemical risks in the food and feed chain. EFSA Supporting Publication 11, EN-547.
46. Ekstrom, G. and Ingelman-Sundberg, M. (1989). Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol 38, 1313-1319. http://dx.doi.org/10.1016/0006-2952(89)90338-9
47. Ellinger-Ziegelbauer, H., Stuart, B., Wahle, B. et al. (2005). Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. Mutat Res 575, 61-84. http://dx.doi.org/10.1016/j.mrfmmm.2005.02.004
48. Ellinger-Ziegelbauer, H., Aubrecht, J., Kleinjans, J. C. et al. (2009). Application of toxicogenomics to study mechanisms of genotoxicity and carcinogenicity. Toxicol Lett 186, 36-44. http://dx.doi.org/10.1016/j.toxlet.2008.08.017
49. Embry, M. R., Bachman, A. N., Bell, D. R. et al. (2014). Risk assessment in the 21st century: Roadmap and matrix. Crit Rev Toxicol 44, Suppl 3, 6-16. http://dx.doi.org/10.3109/10408444 .2014.931924
50. Ferecatu, I., Borot, M. C., Bossard, C. et al. (2010). Polycyclic aromatic hydrocarbon components contribute to the mitochondriaantiapoptotic effect of fine particulate matter on human bronchial epithelial cells via the aryl hydrocarbon receptor. Part Fibre Toxicol 7, 18. http://dx.doi.org/10.1186/1743-8977-7-18
51. Filomeni, G., De Zio, D. and Cecconi, F. (2015). Oxidative stress and autophagy: The clash between damage and metabolic needs. Cell Death Differ 22, 377-388. http://dx.doi.org/10.1038/cdd.2014.150
52. Fjodorova, N., Vracko, M., Novic, M. et al. (2010). New public QSAR model for carcinogenicity. Chem Cent J 4, Suppl 1, S3. http://dx.doi.org/10.1186/1752-153X-4-S1-S3
53. Forcet, C., Ye, X., Granger, L. et al. (2001). The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation. Proc Natl Acad Sci U S A 98, 3416-3421. http://dx.doi.org/10.1073/pnas.051378298
54. Garvey, L. K., Swenberg, J. A., Hamm, T. E. et al. (1987). Di(2-ethylhexyl)phthalate: Lack of initiating activity in the liver of female F-344 rats. Carcinogenesis 8, 285-290. http://dx.doi.org/10.1093/carcin/8.2.285
55. Gibson, D. A. and Saunders, P. T. (2014). Endocrine disruption of oestrogen action and female reproductive tract cancers. Endocr Relat Cancer 21, T13-31. http://dx.doi.org/10.1530/erc-13-0342
56. Go, R. E., Hwang, K. A. and Choi, K. C. (2015). Cytochrome P450 1 family and cancers. J Steroid Biochem Mol Biol 147, 24-30. http://dx.doi.org/10.1016/j.jsbmb.2014.11.003
57. Goll, V., Alexandre, E., Viollon-Abadie, C. et al. (1999). Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures. Toxicol Appl Pharmacol 160, 21-32. http://dx.doi.org/10.1006/taap.1999.8737
58. Goodson, W. H., Lowe, L., Carpenter, D. O. et al. (2015). Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: The challenge ahead. Carcinogenesis 36, S254-S296. http://dx.doi.org/10.1093/carcin/bgv039
59. Gottmann, E., Kramer, S., Pfahringer, B. et al. (2001). Data quality in predictive toxicology: Reproducibility of rodent carcinogenicity experiments. Environ Health Perspect 109, 509-514. http://dx.doi.org/10.1289/ehp.01109509
60. Grady, W. M. (2004). Genomic instability and colon cancer. Cancer Metastasis Rev 23, 11-27. http://dx.doi.org/10.1023/A:1025861527711
61. Gray, G. M., Li, P., Shlyakhter, I. et al. (1995). An empirical examination of factors influencing prediction of carcinogenic hazard across species. Regul Toxicol Pharmacol 22, 283-291. http://dx.doi.org/10.1006/rtph.1995.0011
62. Greally, J. M. and Jacobs, M. N. (2013). In vitro and in vivo testing methods of epigenomic endpoints for evaluating endocrine disruptors. ALTEX 30, 445-471. http://dx.doi.org/10.14573/altex.2013.4.445
63. Hanahan, D. and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70. http://dx.doi.org/10.1016/S0092-8674(00)81683-9
64. Hanahan, D. and Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell 144, 646-674. http://dx.doi.org/10.1016/j.cell.2011.02.013
65. Heindryckx, F., Colle, I. and Van Vlierberghe, H. (2009). Experimental mouse models for hepatocellular carcinoma research. Int J Exp Pathol 90, 367-386. http://dx.doi.org/10.1111/j.1365-2613.2009.00656.x
66. Hartley, P. D. and Madhani, H. D. (2009). Mechanisms that specify promoter nucleosome location and identity. Cell 137, 445-458. http://dx.doi.org/10.1016/j.cell.2009.02.043
67. Hengstler, J. G., Drasdo, D., Celliere, G. et al. (2015). Functional intravital imaging of hepatotoxicity: Comparing intact livers to 3D in vitro systems. Toxicol Lett 238, S38. http://dx.doi.org/10.1016/j.toxlet.2015.08.103
68. Herceg, Z., Lambert, M. P., van Veldhoven, K. et al. (2013). Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation. Carcinogenesis 34, 1955-1967. http://dx.doi.org/10.1093/carcin/bgt212
69. Hernandez, L. G., van Steeg, H., Luijten, M. et al. (2009). Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach. Mutat Res 682, 94-109. http://dx.doi.org/10.1016/j.mrrev.2009.07.002
70. Hiragami-Hamada, K., Xie, S. Q., Saveliev, A. et al. (2009). The molecular basis for stability of heterochromatin-mediated silencing in mammals. Epigenetics Chromatin 2, 14. http://dx.doi.org/10.1186/1756-8935-2-14
71. Hovey, R. C., Coder, P. S., Wolf, J. C. et al. (2011). Quantitative assessment of mammary gland development in female Long Evans rats following in utero exposure to atrazine. Toxicol Sci 119, 380-390. http://dx.doi.org/10.1093/toxsci/kfq337
72. Hu, Z., Brooks, S. A., Dormoy, V. et al. (2015). Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: Focus on the cancer hallmark of tumor angiogenesis. Carcinogenesis 36, Suppl 1, S184-202. http://dx.doi.org/10.1093/carcin/bgv036
73. Huang, G., Cui, F., Yu, F. et al. (2015). Sirtuin-4 (SIRT4) is downregulated and associated with some clinicopathological features in gastric adenocarcinoma. Biomed Pharmacother 72, 135-139. http://dx.doi.org/10.1016/j.biopha.2015.04.013
74. IARC (1991). Captafol. IARC Monogr Eval Carcinog Risks Hum 53, 353-369.
75. IARC (1996). Some pharmaceutical drugs. Lyon, France, 13-20 February 1996. IARC Monogr Eval Carcinog Risks Hum 66, 35-445.
76. IARC (2012). A review of human carcinogens. Part F: Chemical agents and related occupations/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2009: Lyon, France). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 100F.
77. IARC (2013). Some chemicals present in industrial and consumer products, food and drinking-water. IARC Monogr Eval Carcinog Risks Hum 101, 9-549.
78. ICH (2014). ICH harmonised tripartite guideline assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk. M7, Current Step 4 version. http://www.ich.org/fileadmin/Public-Web-Site/ICH-Products/Guidelines/Multidisciplinary/M7/M7-Step-4.pdf
79. Jacobs, M. N., Dickins, M. and Lewis, D. F. (2003). Homology modelling of the nuclear receptors: Human oestrogen receptorbeta (hERbeta), the human pregnane-X-receptor (PXR), the Ah receptor (AhR) and the constitutive androstane receptor (CAR) ligand binding domains from the human oestrogen receptor alpha (hERalpha) crystal structure, and the human peroxisome proliferator activated receptor alpha (PPARalpha) ligand binding domain from the human PPARgamma crystal structure. J Steroid Biochem Mol Biol 84, 117-132. http://dx.doi.org/10.1016/S0960-0760(03)00021-9
80. Jacobs, M. N. (2004). In silico tools to aid risk assessment of endocrine disrupting chemicals. Toxicology 205, 43-53. http://dx.doi.org/10.1016/j.tox.2004.06.036
81. Jaworska, J. and Hoffmann, S. (2010). Integrated Testing Strategy (ITS) -opportunities to better use existing data and guide future testing in toxicology. ALTEX 27, 231-242. http://www.altex.ch/resources/altex-2010-4-231-242-Jaworska-Hoffmann.pdf
82. Jaworska, J., Harol, A., Kern, P. S. et al. (2011). Integrating nonanimal test information into an adaptive testing strategy -skin sensitization proof of concept case. ALTEX 28, 211-225. http://dx.doi.org/10.14573/altex.2011.3.211
83. Jing, H., Vakoc, C. R., Ying, L. et al. (2008). Exchange of GATA factors mediates transitions in looped chromatin organization at a developmentally regulated gene locus. Mol Cell 29, 232-242. http://dx.doi.org/10.1016/j.molcel.2007.11.020
84. Judson, R., Houck, K., Martin, M. et al. (2014). In vitro and modelling approaches to risk assessment from the U.S. Environmental Protection Agency ToxCast programme. Basic Clin Pharmacol Toxicol 115, 69-76. http://dx.doi.org/10.1111/bcpt.12239
85. Khatami, M. (2008). 'Yin and Yang' in inflammation: Duality in innate immune cell function and tumorigenesis. Expert Opin Biol Ther 8, 1461-1472. http://dx.doi.org/10.1517/14712598.8.10.1461
86. Kleinstreuer, N. C., Dix, D. J., Houck, K. A. et al. (2013). In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis. Toxicol Sci 131, 40-55. http://dx.doi.org/10.1093/toxsci/kfs285
87. Klose, R. J. and Bird, A. P. (2006). Genomic DNA methylation: The mark and its mediators. Trends Biochem Sci 31, 89-97. http://dx.doi.org/10.1016/j.tibs.2005.12.008
88. Kravchenko, J., Corsini, E., Williams, M. A. et al. (2015). Chemical compounds from anthropogenic environment and immune evasion mechanisms: Potential interactions. Carcinogenesis 36, Suppl 1, S111-127. http://dx.doi.org/10.1093/carcin/bgv033
89. Kukielka, E. and Cederbaum, A. I. (1992). The effect of chronic ethanol consumption on NADH-and NADPH-dependent generation of reactive oxygen intermediates by isolated rat liver nuclei. Alcohol Alcohol 27, 233-239.
90. Landkocz, Y., Poupin, P., Atienzar, F. et al. (2011). Transcriptomic effects of di-(2-ethylhexyl)-phthalate in Syrian hamster embryo cells: An important role of early cytoskeleton disturbances in carcinogenesis? BMC Genomics 12, 524. http://dx.doi.org/10.1186/1471-2164-12-524
91. Lang, D., Criegee, D., Grothusen, A. et al. (1996). In vitro metabolism of atrazine, terbuthylazine, ametryne, and terbutryne in rats, pigs, and humans. Drug Metab Dispos 24, 859-865.
92. Lang, D. H., Rettie, A. E. and Bocker, R. H. (1997). Identification of enzymes involved in the metabolism of atrazine, terbuthylazine, ametryne, and terbutryne in human liver microsomes. Chem Res Toxicol 10, 1037-1044. http://dx.doi.org/10.1021/tx970081l
93. Lempiainen, H., Muller, A., Brasa, S. et al. (2011). Phenobarbital mediates an epigenetic switch at the constitutive androstane receptor (CAR) target gene Cyp2b10 in the liver of B6C3F1 mice. PLoS One 6, e18216. http://dx.doi.org/10.1371/journal. pone.0018216
94. Lewis, D. F. V. (1996). Cytochromes P450. Structure, Function and Mechanism (348 pp). London: Taylor and Francis Ltd.
95. Lin, L. C., Hsu, S. L., Wu, C. L. et al. (2014). TGFbeta can stimu-selate the p(38)/beta-catenin/PPARgamma signaling pathway to promote the EMT, invasion and migration of non-small cell lung cancer (H460 cells). Clin Exp Metastasis 31, 881-895. http://dx.doi.org/10.1007/s10585-014-9677-y
96. Liu, Q., Li, X., Li, S. et al. (2016). Three novel mutations of APC gene in Chinese patients with familial adenomatous polyposis. Tumour Biol 37, 11421-11427. http://dx.doi.org/10.1007/s13277-016-4986-1
97. Liu, W. M., Pang, R. T., Chiu, P. C. et al. (2012). Sperm-borne microRNA-34c is required for the first cleavage division in mouse. Proc Natl Acad Sci U S A 109, 490-494. http://dx.doi.org/10.1073/pnas.1110368109
98. Lister, R., Pelizzola, M., Dowen, R. H. et al. (2009). Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462, 315-322. http://dx.doi.org/10.1038/nature08514
99. Lo Piparo, E., Worth, A., Manibusan, M. et al. (2011). Use of computational tools in the field of food safety. Regul Toxicol Pharmacol 60, 354-362. http://dx.doi.org/10.1016/j.yrtph.2011.05.003
100. Lo Piparo, E., Maunz, A., Helma, C. et al. (2014). Automated and reproducible read-across like models for predicting carcinogenic potency. Regul Toxicol Pharmacol 70, 370-378. http://dx.doi.org/10.1016/j.yrtph.2014.07.010
101. Lucas, I. K. and Kolodziej, H. (2015). Trans-resveratrol induces apoptosis through ROS-triggered mitochondria-dependent pathways in A549 human lung adenocarcinoma epithelial cells. Planta Med 81, 1038-1044. http://dx.doi.org/10.1055/s-0035-1546129
102. Lv, Z., Cheng, J., Huang, S. et al. (2015). DEHP induces obesity and hypothyroidism through both central and peripheral pathways in C3H/He mice. Obesity (Silver Spring) 24, 368-378. http://dx.doi.org/10.1002/oby.21359
103. Ma, H., Li, J., Yang, J. J. et al. (2012). Di-2-ethylhexyl phthalate and its metabolite single-ethylhexyl phthalate affect TGF-beta 1 expression and telomerase activity in the testis of young male rats. Zhonghua Nan Ke Xue 18, 783-788.
104. Maire, M. A., Rast, C. and Vasseur, P. (2005). Di-(2-ethylhexyl) phthalate (DEHP) increases Bcl-2/Bax ratio and modifies c-myc expression in Syrian hamster embryo (SHE) cells. Toxicol Lett 158, 237-245. http://dx.doi.org/10.1016/j.toxlet.2005.04.004
105. Maire, M. A., Rast, C., Landkocz, Y. et al. (2007). 2,4-Dichlorophenoxyacetic acid: Effects on Syrian hamster embryo (SHE) cell transformation, c-Myc expression, DNA damage and apoptosis. Mutat Res-Gen Toxicol Environ Mutagen 631, 124-136. http://dx.doi.org/10.1016/j.mrgentox.2007.03.008
106. Marczylo, E., Jacobs, M. N. and Gant, T. (2016). Environmentally-induced epigenetic toxicity: Potential public health concerns. Crit Rev Toxicol, in press. http://dx.doi.org/10.1080/104 08444.2016.1175417
107. Marone, P. A., Hall, W. C. and Hayes, A. W. (2014). Reassessing the two-year rodent carcinogenicity bioassay: A review of the applicability to human risk and current perspectives. Regul Toxicol Pharmacol 68, 108-118. http://dx.doi.org/10.1016/j.yrtph.2013.11.011
108. Martens, U., Lennartsson, P., Hogberg, J. et al. (1996). Low expression of the WAF1/CIP1 gene product, p21, in enzyme-altered foci induced in rat liver by diethylnitrosamine or phenobarbital. Cancer Lett 104, 21-26. http://dx.doi.org/10.1016/0304-3835(96)04218-8
109. Marx, U., Walles, H., Hoffmann, S. et al. (2012). 'Human-on-achip' developments: A translational cutting-edge alternative to systemic safety assessment and efficiency evaluation of substances in laboratory animals and man? Altern Lab Anim 40, 235-257.
110. Maunz, A., Gutlein, M., Rautenberg, M. et al. (2013). Lazar: A modular predictive toxicology framework. Front Pharmacol 4, 38. http://dx.doi.org/10.3389/fphar.2013.00038
111. McKee, R. H. (2000). The role of inhibition of gap junctional intercellular communication in rodent liver tumor induction by phthalates: Review of data on selected phthalates and the potential relevance to man. Regul Toxicol Pharmacol 32, 51-55. http://dx.doi.org/10.1006/rtph.2000.1407
112. Meek, M. E., Boobis, A., Cote, I. et al. (2014). New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis. J Appl Toxicol 34, 1-18. http://dx.doi.org/10.1002/jat.2949
113. Mehlen, P. and Fearon, E. R. (2004). Role of the dependence receptor DCC in colorectal cancer pathogenesis. J Clin Oncol 22, 3420-3428. http://dx.doi.org/10.1200/jco.2004.02.019
114. Meissner, A., Mikkelsen, T. S., Gu, H. et al. (2008). Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454, 766-770. http://dx.doi.org/10.1038/nature07107
115. Melnick, R. L. (2001). Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)? Environ Health Perspect 109, 437-442. http://dx.doi.org/10.1289/ehp.01109437
116. Mikkelsen, T. S., Ku, M., Jaffe, D. B. et al. (2007). Genomewide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448, 553-560. http://dx.doi.org/10.1038/nature06008
117. Miousse, I. R., Currie, R., Datta, K. et al. (2015). Importance of investigating epigenetic alterations for industry and regulators: An appraisal of current efforts by the Health and Environmental Sciences Institute. Toxicology 335, 11-19. http://dx.doi.org/10.1016/j.tox.2015.06.009
118. Mitra, A. P., Datar, R. H. and Cote, R. J. (2006). Molecular pathways in invasive bladder cancer: New insights into mechanisms, progression, and target identification. J Clin Oncol 24, 5552-5564. http://dx.doi.org/10.1200/jco.2006.08.2073
119. Moggs, J. G., Goodman, J. I., Trosko, J. E. et al. (2004). Epigenetics and cancer: Implications for drug discovery and safety assessment. Toxicol Appl Pharmacol 196, 422-430. http://dx.doi.org/10.1016/j.taap.2004.01.009
120. Murphy, K. A., Villano, C. M., Dorn, R. et al. (2004). Interaction between the aryl hydrocarbon receptor and retinoic acid pathways increases matrix metalloproteinase-1 expression in keratinocytes. J Biol Chem 279, 25284-25293. http://dx.doi.org/10.1074/jbc.M402168200
121. Murray, I. A., Patterson, A. D. and Perdew, G. H. (2014). Aryl hydrocarbon receptor ligands in cancer: Friend and foe. Nat Rev Cancer 14, 801-814. http://dx.doi.org/10.1038/nrc3846
122. Nagalakshmi, U., Wang, Z., Waern, K. et al. (2008). The transcriptional landscape of the yeast genome defined by RNA se quencing. Science 320, 1344-1349. http://dx.doi.org/10.1126/science.1158441
123. Nakanishi, K., Sakamoto, M., Yamasaki, S. et al. (2005). Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma. Cancer 103, 307-312. http://dx.doi.org/10.1002/cncr.20774
124. Narayanan, K. B., Ali, M., Barclay, B. J. et al. (2015). Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death. Carcinogenesis 36, S89-110. http://dx.doi.org/10.1093/carcin/bgv032
125. NAS -National Academy of Sciences (2007). Toxicity Testing in the 21st Century. 216 pp.
126. Newbold, R. R., Padilla-Banks, E. and Jefferson, W. N. (2006). Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology 147, S11-17. http://dx.doi.org/10.1210/en.2005-1164
127. Nieminen, T., Toivanen, P. I., Rintanen, N. et al. (2014). The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features. Biochim Biophys Acta 1840, 454-463. http://dx.doi.org/10.1016/j.bbagen. 2013.10.005
128. Nishida, N. and Kudo, M. (2013). Oxidative stress and epigenetic instability in human hepatocarcinogenesis. Dig Dis 31, 447-453. http://dx.doi.org/10.1159/000355243
129. NTP -National Toxicology Program (2006). NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies). Natl Toxicol Program Tech Rep Ser, 4-232.
130. NTP (2008). Final report on carcinogens background document for captafol. Rep Carcinog Backgr Doc i-xvi, 1-99. http://ntp.niehs. nih.gov/pubhealth/roc/roc13/
131. NTP (2011). Captafol. Rep Carcinog 12, 83-86. http://ntp.niehs. nih.gov/pubhealth/roc/roc13/
132. NTP (2014). Report on Carcinogens. Thirteenth Edition. Research Triangle Park, NC: U.S Department of Health and Human Services, Public Health Service. http://ntp.niehs.nih.gov/pubhealth/roc/roc13/
133. OECD (2007). Detailed review paper on cell transformation assays for detection of chemical carcinogens. Series on Testing and Assessment 31.
134. OECD (2011). Test No. 456: H295R Steroidogenesis Assay. http://dx.doi.org/10.1787/9789264122642-en
135. OECD (2012a). Test No. 455: Performance-Based Test Guideline for Stably Transfected Transactivation In Vitro Assays to Detect Estrogen Receptor Agonists. http://dx.doi.org/10.1787/9789264185388-en
136. OECD (2012b). Peer Review Report related to three cell transformation assays and agreement of the working group of the National Coordinators of the Test Guidelines Programme on the follow-up to the peer review. Series on Testing and Assessment 163.
137. OECD (2013). Guidance Document on Developing And Assessing Adverse Outcome Pathways. Series on Testing and Assessment 184.
138. OECD (2014). Guidance on Grouping of Chemicals. Second edi tion. Series on Testing and Assessment 194. http://www.oecd. org/officialdocuments/publicdisplaydocumentpdf/?cote=env/jm/mono(2014)4&doclanguage=en
139. OECD (2015a). Guidance Document on the in vitro syrian hamster embrtyo (SHE) Cell Transformation Assay. Series on Testing and Assessment 214. ENV/JM/MONO(2015)18. http://www.oecd.org/env/ehs/testing/Guidance-Document-on-the-in-vitro-Syrian-Hamster-Embryo-Cell-Transformation-Assay.pdf
140. OECD (2015b). Report of the workshop on a framework for the development and use of integrated approaches to testing and assessment. Series on Testing and Assessment 215. http://dx.doi.org/ENV/JM/MONO(2015)22
141. OECD (2015c). Fundamental and Guiding Principles for (Q)SAR Analysis Of Chemical Carcinogens With Mechanistic Considerations. Series on Testing and Assessment 229. http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=e nv/jm/mono(2015)46&doclanguage=en
142. Ostling, P., Leivonen, S. K., Aakula, A. et al. (2011). Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells. Cancer Res 71, 1956-1967. http://dx.doi.org/10.1158/0008-5472.can-10-2421
143. Pant, K., Sly, J. E., Bruce, S. W. et al. (2010). Syrian hamster embryo (SHE) cell transformation assay with and without X-ray irradiation of feeder cells using Di(2-ethylhexyl)phthalate (DEHP) and N-nitroso-N-methylnitroguanidine (MNNG). Mutat Res 698, 6-10. http://dx.doi.org/10.1016/j.mrgentox.2010.02.017
144. Paolillo, N., Piccirilli, S., Giardina, E. et al. (2011). Effects of paraquat and capsaicin on the expression of genes related to inflammatory, immune responses and cell death in immortalized human HaCat keratinocytes. Int J Immunopathol Pharmacol 24, 861-868.
145. Patlewicz, G., Jeliazkova, N., Safford, R. J. et al. (2008). An evaluation of the implementation of the Cramer classification scheme in the Toxtree software. SAR QSAR Environ Res 19, 495-524. http://dx.doi.org/10.1080/10629360802083871
146. Paparella, M., Daneshian, M., Hornek-Gausterer, R. et al. (2013). Uncertainty of testing methods -what do we (want to) know? ALTEX 30, 131-144. http://dx.doi.org/10.14573/altex.2013.2.131
147. Paparella, M., Colacci, A, Jacobs, M. N. (2016). What do we (want to) know about carcinogenicity? ALTEX Epub Oct 25. http://dx.doi.org/10.14573/altex.1608281
148. Parke, D. V. (1994). The cytochromes P450 and mechanisms of chemical carcinogenesis. Environ Health Perspect 102, 852-853. http://dx.doi.org/10.1289/ehp.94102852
149. Perocco, P., Colacci, A., Delciello, C. et al. (1995). Transformation of BALB/C 3T3 cells in vitro by the fungicides Captan, Captafol and Folpet. Jpn J Cancer Res 86, 941-947. http://dx.doi.org/10.1111/j.1349-7006.1995.tb03005.x
150. Prestigiacomo, V. and Suter-Dick, L. (2015). Human 3D-model for the investigation of hepatic fibrosis. Toxicol Lett 238, S281. http://dx.doi.org/10.1016/j.toxlet.2015.08.809
151. Quignot, N., Desmots, S., Barouki, R. et al. (2012). A comparison of two human cell lines and two rat gonadal cell primary cultures as in vitro screening tools for aromatase modulation. Toxicol In Vitro 26, 107-118. http://dx.doi.org/10.1016/j.tiv.2011.11.004
152. Rahden-Staron, I., Czeczot, H. and Szumilo, M. (2001). Induction of rat liver cytochrome P450 isoenzymes CYP 1A and CYP 2B by different fungicides, nitrofurans, and quercetin. Mutat Res 498, 57-66. http://dx.doi.org/10.1016/S1383-5718(01)00267-4
153. Rakitsky, V. N., Koblyakov, V. A. and Turusov, V. S. (2000). Nongenotoxic (epigenetic) carcinogens: Pesticides as an example. A critical review. Teratog Carcinog Mutagen 20, 229-240. http://dx.doi.org/10.1002/1520-6866(2000)20:4229::AID-TCM53.0.CO;2-M
154. Ramachandran, S. D., Schirmer, K., Munst, B. et al. (2015). In vitro generation of functional liver organoid-like structures using adult human cells. PLoS One 10, e0139345. http://dx.doi.org/10.1371/journal.pone.0139345
155. Rathmell, K. W., Chen, F. and Creighton, C. J. (2015). Genomics of chromophobe renal cell carcinoma: Implications from a rare tumor for pan-cancer studies. Oncoscience 2, 81-90. http://dx.doi.org/10.18632/oncoscience.130
156. Ren, H., Aleksunes, L. M., Wood, C. et al. (2010). Characterization of peroxisome proliferator-activated receptor alpha -independent effects of PPARalpha activators in the rodent liver: di-(2-ethylhexyl) phthalate also activates the constitutive-activated receptor. Toxicol Sci 113, 45-59. http://dx.doi.org/10.1093/toxsci/kfp251
157. Rieger, A. M., Nelson, K. L., Konowalchuk, J. D. et al. (2011). Modified annexin V/propidium iodide apoptosis assay for accurate assessment of cell death. J Vis Exp 50, e2597. http://dx.doi.org/10.3791/2597
158. Rovida, C., Alepee, N., Api, A. M. et al. (2015). Integrated Testing Strategies (ITS) for safety assessment. ALTEX 32, 25-40. http://dx.doi.org/10.14573/altex.1411011
159. Roy, D., Yu, K. and Lieber, M. R. (2008). Mechanism of R-loop formation at immunoglobulin class switch sequences. Mol Cell Biol 28, 50-60. http://dx.doi.org/10.1128/MCB.01251-07
160. Sanderson, J. T., Seinen, W., Giesy, J. P. et al. (2000). 2-Chloros-triazine herbicides induce aromatase (CYP19) activity in H295R human adrenocortical carcinoma cells: A novel mechanism for estrogenicity? Toxicol Sci 54, 121-127. http://dx.doi.org/10.1093/toxsci/54.1.121
161. Schaap, M. M., Zwart, E. P., Wackers, P. F. et al. (2012). Dissecting modes of action of non-genotoxic carcinogens in primary mouse hepatocytes. Arch Toxicol 86, 1717-1727. http://dx.doi.org/10.1007/s00204-012-0883-6
162. Schaap, M. M., Wackers, P. F., Zwart, E. P. et al. (2015). A novel toxicogenomics-based approach to categorize (non-)genotoxic carcinogens. Arch Toxicol 89, 2413-2427. http://dx.doi.org/10.1007/s00204-014-1368-6
163. Serafimova, R., Todorov, M., Nedelcheva, D. et al. (2007). QSAR and mechanistic interpretation of estrogen receptor binding. SAR QSAR Environ Res 18, 389-421. http://dx.doi.org/10.1080/10629360601053992
164. Serezani, C. H., Ballinger, M. N., Aronoff, D. M. et al. (2008). Cyclic AMP: Master regulator of innate immune cell function. Am J Respir Cell Mol Biol 39, 127-132. http://dx.doi.org/10.1165/rcmb.2008-0091TR
165. Silva Lima, B. and Van der Laan, J. W. (2000). Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard. Regul Toxicol Pharmacol 32, 135-143. http://dx.doi.org/10.1006/rtph.2000.1427
166. Simpkins, J. W., Swenberg, J. A., Weiss, N. et al. (2011). Atrazine and breast cancer: A framework assessment of the toxicological and epidemiological evidence. Toxicol Sci 123, 441-459. http://dx.doi.org/10.1093/toxsci/kfr176
167. Sistare, F. D., Morton, D., Alden, C. et al. (2011). An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: Support for a proposal to modify current regulatory guidelines. Toxicol Pathol 39, 716-744. http://dx.doi.org/10.1177/0192623311406935
168. Skeberdis, V. A., Lan, J., Opitz, T. et al. (2001). mGluR1-mediated potentiation of NMDA receptors involves a rise in intracellular calcium and activation of protein kinase C. Neuropharmacology 40, 856-865. http://dx.doi.org/10.1016/S0028-3908(01)00005-3
169. Smith, M. T., Guyton, K. Z., Gibbons, C. F. et al. (2015). Key characteristics of carcinogens as a basis for organizing data on mechanisms of carcinogenesis. Environ Health Perspect 124, 713-721. http://dx.doi.org/10.1289/ehp.1509912
170. Soldatow, V. Y., Lecluyse, E. L., Griffith, L. G. et al. (2013). models for liver toxicity testing. Toxicol Res (Camb) 2, 23-39. http://dx.doi.org/10.1039/c2tx20051a
171. Song, H., Zhang, T., Yang, P. et al. (2015). Low doses of bisphenol A stimulate the proliferation of breast cancer cells via ERK1/2/ERRgamma signals. Toxicol In Vitro 30, 521-528. http://dx.doi.org/10.1016/j.tiv.2015.09.009
172. Song, L. and Crawford, G. E. (2010). DNase-seq: A high-resolution technique for mapping active gene regulatory elements across the genome from mammalian cells. Cold Spring Harb Protoc 2010, pdb prot5384. http://dx.doi.org/10.1101/pdb.prot5384
173. Sonnenschein, C. and Soto, A. M. (2013). The aging of the 2000 and 2011 hallmarks of cancer reviews: A critique. J Biosci 38, 651-663. http://dx.doi.org/10.1007/s12038-013-9335-6
174. Suh, D. H., Kim, M. K., Kim, H. S. et al. (2013). Mitochondrial permeability transition pore as a selective target for anticancer therapy. Front Oncol 3, 41. http://dx.doi.org/10.3389/fonc.2013.00041
175. Suzuki, M., Jing, Q., Lia, D. et al. (2010). Optimized design and data analysis of tag-based cytosine methylation assays. Genome Biol 11, R36. http://dx.doi.org/10.1186/gb-2010-11-4-r36
176. Swierenga, S. H. and Yamasaki, H. (1992). Performance of tests for cell transformation and gap junction intercellular communication for detecting nongenotoxic carcinogenic activity. IARC Sci Publ 116, 165-193.
177. Tanay Das, M., Kumar, M. and Thakur, I. S. (2014). Differential toxicological endpoints of di(2-ethylhexyl) phthalate (DEHP) exposure in MCF-7 and MDA-MB-231 cell lines: Possible estrogen receptor alpha (ERalpha) independent modulations. Indian J Exp Biol 52, 1052-1061.
178. Thomson, J. P., Lempiainen, H., Hackett, J. A. et al. (2012). Nongenotoxic carcinogen exposure induces defined changes in the 5-hydroxymethylome. Genome Biol 13, R93. http://dx.doi.org/10.1186/gb-2012-13-10-r93
179. Thomson, J. P., Moggs, J. G., Wolf, C. R. et al. (2014). Epigenetic profiles as defined signatures of xenobiotic exposure. Mutat Res Genet Toxicol Environ Mutagen 764-765, 3-9. http://dx.doi.org/10.1016/j.mrgentox.2013.08.007
180. Tollefsen, K. E., Scholz, S., Cronin, M. T. et al. (2014). Applying adverse outcome pathways (AOPs) to support integrated approaches to testing and assessment (IATA). Regul Toxicol Pharmacol 70, 629-640. http://dx.doi.org/10.1016/j.yrtph.2014.09.009
181. US EPA Office of Pesticide Programs (2002). The Grouping of a Series of Triazine Pesticides Based on a Common Mechanism of Toxicity.
182. US EPA (2005). Guidelines for carcinogen risk assessment and supplemental guidance for assessing susceptibility from earlylife exposure to carcinogens. Federal Register 70, 17765-17817.
183. Vaccari, M., Mascolo, M. G., Rotondo, F. et al. (2015). Identification of pathway-based toxicity in the BALB/c 3T3 cell model. Toxicol In Vitro 29, 1240-1253. http://dx.doi.org/10.1016/j.tiv.2014.10.002
184. Vainio, H., Magee, P., McGregor, D. B. and McMichael, A. J. (eds.) (1992). Mechanisms of Carcinogenesis in Risk Identification. IARC Scientific Publication 116, 629.
185. van Grunsven, L. (2015). A 3D liver co-culture system for evaluating drug-induced adverse outcome pathways leading to fibrosis. Toxicol Lett 238, S38-S39. http://dx.doi.org/10.1016/j.toxlet.2015.08.104
186. Vermeire, T., Stevenson, H., Peiters, M. N. et al. (1999). Assessment factors for human health risk assessment: A discussion paper. Crit Rev Toxicol 29, 439-490. http://dx.doi.org/10.1080/10408449991349249
187. Viljoen, K. S., Dakshinamurthy, A., Goldberg, P. et al. (2015). Quantitative profiling of colorectal cancer-associated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer. PLoS One 10, e0119462. http://dx.doi.org/10.1371/journal.pone.0119462
188. Villeneuve, D. L., Crump, D., Garcia-Reyero, N. et al. (2014). Adverse outcome pathway (AOP) development I: Strategies and principles. Toxicol Sci 142, 312-320. http://dx.doi.org/10.1093/toxsci/kfu199
189. Wang, C., Yang, C., Chen, X. et al. (2011). Altered profile of seminal plasma microRNAs in the molecular diagnosis of male infertility. Clin Chem 57, 1722-1731. http://dx.doi.org/10.1373/clinchem.2011.169714
190. WHO (2007). IPCS framework for analysing the relevance of a cancer mode of action for humans and case studies. Harmonization Project Document No. 4.
191. WHO (2014). Guidance Document on evaluating and expressing uncertainty in hazard characterization. Harmonization Project Document No. 11.
192. Wong, R. L. and Walker, C. L. (2013). Molecular pathways: Environmental estrogens activate nongenomic signaling to developmentally reprogram the epigenome. Clin Cancer Res 19, 3732-3737. http://dx.doi.org/10.1158/1078-0432.ccr-13-0021
193. Woo, Y. T. and Lai, D. Y. (2003). Mechanism of action of chemical carcinogens and their role in structure-activity relationships analysis and risk assessment. In R. Benigni (eds.), Quantitative Structure-Activity Relationship (QSAR) Analysis of Mutagens and Carcinogens. CRC Press.
194. Wu, S., Blackburn, K., Amburgey, J. et al. (2010). A framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogs for SAR-based toxicological assessments. Regul Toxicol Pharmacol 56, 67-81. http://dx.doi.org/10.1016/j.yrtph.2009.09.006
195. Wu, Q. and Ni, X. (2015). ROS-mediated DNA methylation pattern alterations in carcinogenesis. Curr Drug Targets 16, 13-19. http://dx.doi.org/10.2174/1389450116666150113121054
196. Yang, W. and Tiffany-Castiglioni, E. (2008). Paraquat-induced apoptosis in human neuroblastoma SH-SY5Y cells: Involvement of p53 and mitochondria. J Toxicol Environ Health A 71, 289-299. http://dx.doi.org/10.1080/15287390701738467
197. Zhang, H., Zhang, Z., Nakanishi, T. et al. (2015). Structure-dependent activity of phthalate esters and phthalate monoesters binding to human constitutive androstane receptor. Chem Res Toxicol 28, 1196-1204. http://dx.doi.org/10.1021/acs.chemrestox.5b00028
198. Zhang, X. and Ho, S. M. (2011). Epigenetics meets endocrinology. J Mol Endocrinol 46, R11-32. http://dx.doi.org/10.1677/JME-10-0053